NCT04150484

Brief Summary

ABSTRACT BACKGROUND: Breast Cancer (BC) is one of the leading causes of death among women around the world. Integrative oncology, together with conventional medical treatment, has proven to be an important support for the control of cancer symptoms, improvement of quality of life, and contribution to the overall patient health, providing an integrated patient care both physically and emotionally. METHODS: 75 stage II-III breast cancer survivors were randomized (according to age, tumor stage and receptor status) into 2 groups: intervention and control. Within the intervention group (IG) a diet, exercise and mindfulness intervention was performed, while the control group (CG) did not receive any sort of treatment, during 6 months. Passed (at the beginning and end of the research) questionnaires concerning general health, quality of life (EORTC QLQ-C30 and BR23), and diet (Mediterranean diet adherence test and 24-h-recall) and a blood and urine sample was collected to analyze general biochemical variables. RESULTS:

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
67

participants targeted

Target at P25-P50 for not_applicable breast-cancer

Timeline
Completed

Started Dec 2016

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2016

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 23, 2017

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 25, 2019

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

October 20, 2019

Completed
15 days until next milestone

First Posted

Study publicly available on registry

November 4, 2019

Completed
Last Updated

November 4, 2019

Status Verified

October 1, 2019

Enrollment Period

1.1 years

First QC Date

October 20, 2019

Last Update Submit

October 31, 2019

Conditions

Keywords

breast cancer survivalmediterranean dietphysical activitymindfulness

Outcome Measures

Primary Outcomes (1)

  • Quality of life test (EORTC QOL-C30)

    It includes 30 items that are grouped into five scales functional (physical, social, emotional functioning, cognitive and role), three scales of symptoms (fatigue, pain, nausea and vomiting), a global scale of health / quality of life and a number of related individual items with the symptoms of the disease and its treatment, as well as an item of economic impact. The answers to the items on the scales refer to "last week," except the patient's physical functioning scale whose time frame is the present. These answers they obey a Likert format, which ranges from 1 ("Not at all") and 4 ("A lot")

    6 months

Secondary Outcomes (5)

  • Mediterranean diet adherence test

    6 months

  • Levels of glucose

    6 months

  • Levels of triglycerides

    6 months

  • Levels of cholesterol

    6 months

  • 24 hours recall

    6 months

Study Arms (2)

interventional group

OTHER

dietary intervention, physical exercise and mindfulness

Other: Mediterranean diet, physical exercise and mindfulness workshops

control group

NO INTERVENTION

Group without any intervention.

Interventions

a group of dietary intervention, physical exercise and mindfulness and another control group, and a longitudinal follow-up was carried out for 6 months from the beginning of the intervention.

interventional group

Eligibility Criteria

Age18 Years - 70 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients between 18 and 70 years of age
  • Breast cancer IIA-IIB operable in follow-up
  • Seen in the Oncology service of the Virgen de las Nieves Hospital in Granada
  • Residents in the city or metropolitan area of Granada

You may not qualify if:

  • Those who presented some physical or psychic limitation that prevented the intervention from being carried out were excluded from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Ruiz-Vozmediano J, Lohnchen S, Jurado L, Recio R, Rodriguez-Carrillo A, Lopez M, Mustieles V, Exposito M, Arroyo-Morales M, Fernandez MF. Influence of a Multidisciplinary Program of Diet, Exercise, and Mindfulness on the Quality of Life of Stage IIA-IIB Breast Cancer Survivors. Integr Cancer Ther. 2020 Jan-Dec;19:1534735420924757. doi: 10.1177/1534735420924757.

MeSH Terms

Conditions

Breast NeoplasmsMotor Activity

Interventions

Diet, MediterraneanExercise

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesBehavior

Intervention Hierarchy (Ancestors)

Diet, Plant-BasedDiet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological PhenomenaMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Julia Ruiz Vozmediano, Dr

    Hospital Virgen de las Nieves

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Patients between 18 and 70 years of age with breast cancer II-III operable in follow-up, seen in the Oncology service of the Virgen de las Nieves Hospital in Granada and residents in the city or metropolitan area of Granada, which had completed, in the 12 months prior to its inclusion, treatment with surgery, radiotherapy and / or systemic chemotherapy treatment (including biological treatment). Randomized assignment was made based on age, stage, hormone receptor and her2 status, establishing two groups: a group of dietary intervention, physical exercise and mindfulness and another control group. A longitudinal follow-up was carried out for 6 months from the beginning of the intervention.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

October 20, 2019

First Posted

November 4, 2019

Study Start

December 1, 2016

Primary Completion

December 23, 2017

Study Completion

May 25, 2019

Last Updated

November 4, 2019

Record last verified: 2019-10

Data Sharing

IPD Sharing
Will share

All IPD that and underlie result in a publication

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
Depends of the journal
Access Criteria
Depends of the journal